A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Kidney Int. 2022 May;101(5):1073-1076. doi: 10.1016/j.kint.2022.02.011. Epub 2022 Feb 26.
No abstract available

Keywords: Delta variant; SARS-CoV-2; fourth dose; kidney transplantation; mRNA vaccine; neutralizing antibodies.

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Kidney Transplantation*
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273

Supplementary concepts

  • SARS-CoV-2 variants